| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |